London - Institute of Cancer Research

ICR ECMC

The Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust is committed to optimizing the early development of rationally designed, novel anti-cancer drugs, which target molecular abnormalities and key cellular switches hijacked by cancer cells. Areas of expertise include molecular pharmacodynamics, diagnostics (including DNA sequencing) and imaging (MRI and PET). Like other Centres the ICR works with other ECMCs to conduct early phase clinical trials.

Clinical Focus Area

  • Early clinical trials


 

Scientific Focus Area

  • Cell signalling
  • DNA repair
  • Circulating biomarkers
 

Disease Focus Area

Breast Colorectal Kidney Lung
Melanoma Ovarian Pancreatic Prostate
Sarcoma      
 

Goals

Goals

For further information on the goals and objectives of ICR ECMC go to:

More about Goals

 

Skills

Skills

ICR ECMC principal investigators and staff have a diverse range of skills and expertise.

More about Skills

 

Facilities

Facilities

ICR ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities